use of medicine : Pfizer, BioNTech apply for FDA authorization of Omicron-targeting booster dose

Monday, August 22, 2022

Pfizer, BioNTech apply for FDA authorization of Omicron-targeting booster dose

WASHINGTON — The Pfizer and BioNTech firms have completed a submission to the US Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron BA.4/BA.5-adapted

from https://ift.tt/Afjb8Xs https://ift.tt/ovpkUCY

No comments:

Post a Comment

Featured Post

benefits of kismiss